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The Potential of Silk and Silk-Like
Proteins as Natural Mucoadhesive
Biopolymers for Controlled Drug
Delivery
Amanda E. Brooks*
Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, USA
Drug delivery across mucus membranes is a particularly effective route of administration
due to the large surface area. However, the unique environment present at the
mucosa necessitates altered drug formulations designed to (1) deliver sensitive biologic
molecules, (2) promote intimate contact between the mucosa and the drug, and (3)
prolong the drug’s local residence time. Thus, the pharmaceutical industry has an
interest in drug delivery systems formulated around the use of mucoadhesive polymers.
Mucoadhesive polymers, both synthetic and biological, have a history of use in local
drug delivery. Prominently featured in the literature are chitosan, alginate, and cellulose
derivatives. More recently, silk and silk-like derivatives have been explored for their
potential as mucoadhesive polymers. Both silkworms and spiders produce sticky silk-like
glue substances, sericin and aggregate silk respectively, that may prove an effective,
natural matrix for drug delivery to the mucosa. This mini review will explore the potential
of silk and silk-like derivatives as a biocompatible mucoadhesive polymer matrix for local
controlled drug delivery.
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INTRODUCTION
The rising need for tissue compatible adhesives is expected to generate a $38 billion global market
by 2017 (Bré et al., 2013). A subset of this market is being driven by the pharmaceutical industry.
Localized transmucosal drug delivery constitutes a large and growing share of the market, with an
estimated value of $6.7 million (U.S.) in 2006 (Andrews et al., 2009) and $2.91 billion (global)
in 2013 (Micromarket Monitor1). Based on a compound annual growth rate of 6.8%, global
transmucosal drug delivery is projected to be a $4.05 billion market segment by 2018 (Micromarket
Monitor). This growingmarket is demanding a new and diverse set of polymers. Local drug delivery
and retention, particularly at a biological surface, can often be accomplished through the use of
bioadhesive polymers. Mucoadhesives, a class of bioadhesives, serve a critical niche in transmucosal
drug delivery as the unique environment at the mucosal surface requires altered drug formulations.
The mucosal membrane is typically composed of a specialized epithelial cell layer covered with
mucin to facilitate gas and nutrient exchange (Yu et al., 2014). The physiological function of the
1Micromarket Monitor Global Transmucosal Drug Delivery Market Research Report. Available online at: http://
www.micromarketmonitor.com/market-report/transmucosal-drug-delivery-reports-5655777892.html [Accessed August 24,
2015].
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mucosal membrane can be exploited to facilitate pharmaceutical
dosing. Mucoadhesive polymers, including both synthetic and
natural polymers, have generated intense and growing interest
in the past decades (Grabovac et al., 2005; Khutoryanskiy,
2011; Mythri et al., 2011). In addition to a host of synthetic
polymers, prominently featured in the literature are chitosan,
alginate and cellulose derivatives. Recently, several silk and silk-
like derivatives have been evaluated for their adhesive properties.
This mini review will describe the mucoadhesive properties of
silk and silk-like derivatives that justify them being explored
as biocompatible mucoadhesive polymer matrices for localized,
controlled transmucosal drug delivery.
MECHANISMS OF MUCOADHESION
A variety of mucous membranes exist throughout the human
body to lubricate and protect the interface between the internal
and external environments of the body. Several good reviews
describing the characterization and central role of mucin in
mucousmembranes are available and will not be further reviewed
here except to say that the mucin component of the mucous
membrane forms a glyocoprotein gel-like network that proves
critical to mucoadhesion (Marriott and Gregory, 1990; Smart,
2005; Andrews et al., 2009; Khutoryanskiy, 2011; Yu et al., 2014).
Although the precise mucin organization and identification may
vary based on mucosal location (i.e., nose, eye mouth, stomach,
intestine, vagina), there are six main theories of mucoadhesion
with many principles of mucoadhesion remaining consistent:
(1) the wetting theory, which describes mucoadhesion as a
product of the intermolecular interactions and interfacial tension
between themucosal surface and the adhesive; (2) themechanical
interlocking theory, which proposes that mucoadhesion results
from the mechanical interlocking of the adhesive and features
of the substrate surface; (3) the electronic transfer theory, where
electrons transfer between the adhesive and the surface creating
critical electrostatic forces; (4) the diffusion interpenetration
theory, which describes mucoadhesion as a result of the
interpenetration and entanglement of polymer and mucin chains
dominated by electrostatic attractions; (5) the adsorption theory,
which describes mucoadhesion as being an accumulation of
primary (i.e., ionic and covalent) and secondary (i.e., van der
Waals forces, hydrogen bonding, electrostatic attraction, and
hydrogen bonds) bond formation; and (6) the fracture theory,
which does not offer a chemical or molecular explanation
of mucoadhesion but simply relates the adhesive strength to
that necessary to separate the adhesive and mucous membrane
(Smart, 2005; Andrews et al., 2009; Shaikh et al., 2011; Tangri,
2011; Yu et al., 2014). Importantly, the underlying mechanism
of mucoadhesion is not completely clear and may result from
a combination of these theories (Smart, 2005); furthermore,
the adhesive strength and consequently the utility of different
mucoadesive polymers is not the same for all mucousmembranes
(Accili et al., 2004). Notably, certain mucoadhesive polymers,
including natural biopolymers, may have altered degradation in
the GI tract due to the presence of the microbiome or other
pathological conditions [i.e., inflammation, ulcerative colitis, etc.
(Seves et al., 1998; Hua et al., 2015)]. Thus, awareness of the
theories is essential to the design of mucoadhesive polymers for
drug delivery systems.
MUCOADHESIVE POLYMERS
Regardless of the specific mucoadhesive mechanism, there
are some promising candidate polymers in development for
drug delivery. General characteristics and classifications of
mucoadhesive polymers are presented in this review with
examples to illustrate their utility as drug delivery systems
opposed to an in depth discussion of all possible polymers.
Characteristics of Polymers
The appropriate polymer choice for local mucoadhesive drug
delivery relies on a combination of (1) the polymer’s chemical
reactivity and stereochemistry, (2) its molecular weight and
concentration, (3) its side group flexibility and steric hindrance,
and (4) its ability to swell and adhere to tissues under moist or
high humidity conditions (Andrews et al., 2009; Shaikh et al.,
2011; Tangri, 2011). Commonly used mucoadhesive polymers
generally have polar groups (hydroxyl, carboxyl, amide, sulfate)
available for interaction with mucin as well as molecular weights
that fall in the range of 104 Da to 4 × 106 Da to facilitate the
interaction (Smart, 2005; Andrews et al., 2009). Polymers that fall
on the upper end of this range may not have sufficient flexibility
to swell and adhere while those that are below this range will
only form weak adhesives and readily dissipate. First generation
or non-specific mucoadhesive polymers, whether synthetic or
natural, are generally hydrophilic with functional groups that
allow for hydrogen bonding and electrostatic interactions.
Alternatively, second generation mucoadhesive polymers such as
lectins (Clark et al., 2000; Lehr, 2000; Haas and Lehr, 2002; Kim
et al., 2015), invasins, thiolated polymers (Bernkop-Schnürch
et al., 2004b; Cevher et al., 2008a,b), antibodies, and other
proteins (Woodley, 2001; Bravo-Osuna et al., 2007) are developed
to facilitate specific interactions and overcome biological barriers
(Carvalho et al., 2010). A review of synthetic mucoadhesive
polymers will not be presented in this mini-review, but instead
the reader is referred to several reviews on the subject (Grabovac
et al., 2005; Ludwig, 2005; Salamat-Miller et al., 2005; Valenta,
2005; Catron et al., 2006; Andrews et al., 2009; Carvalho et al.,
2010; Mythri et al., 2011; Yu et al., 2014).
Natural Polymers
In this synthetic landscape, a host of natural polymers have
been explored as mucoadhesive drug carriers (Ceulemans
et al., 2002; George and Abraham, 2006; Wittaya-areekul et al.,
2006; Kalu et al., 2007) and are often preferred for biomedical
applications due to their reputation for “green” processing,
renewability, and biocompatibility (Ngwuluka et al., 2014).
Notably, biocompatibility, specifically immunocompatibility,
may be a product of purity, which could be challenging for
natural sources (Lehr, 2000). Many naturally mucoadhesive
polymers are very large polymeric proteins and have repetitive
patterned structural elements organized in a structural
hierarchy, particularly in the silks (Table 1). The mechanism
of mucoadhesion for many of these natural polymers seems
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TABLE 1 | Comparison of the repetitive primary structural elements of natural adhesive polymers.
Natural polymer Amino acid motif/Chemical
structure
Ecological purpose Adhesion
strength
References
Sericin (SSTGSSSNTDSNSNSVGSS
TSGGSSTYGYSSNSRDGSV)n
Sticky outside
coating
4.1 ± 2 N Ahn et al., 2001
Silkworm firboin GAGAGS, GXn, where X = A, Y, V Core of silk fiber 54mN or 146.6
mN/cm2
Jiang et al., 2006;
Kundu et al., 2008a
Aggregate silk Gly-rich (64-mer), XPGXG (36-mer,)
GGX/NXNXN (33-mer)
Aqueous glue for web 0.1–0.4mN Sahni et al., 2011;
Vasanthavada et al.,
2012; Opell et al., 2013
Piriform silk QQSSVA, PXPXP Attachment cement 39.8 ± 8.9mN Perry et al., 2010;
Grawe et al., 2014;
Wolff et al., 2015
Caddisfly silk O-phospho-ser cluster (SX)n where X =
V, L, I, R; and n is 2–6
Underwater cement
for protective case
32.7 ± 6.6MPa
(stress at fracture)
Ohkawa et al., 2013;
Lane et al., 2015
Chitosan Shellfish 32.4 ± 14.5 mN
3.9–6.7 mN/cm2
Bernkop-Schnürch and
Freudl, 1999; Lehr
et al., 1992
Note that the values for adhesion strength cannot be compared due to different techniques used to gather the data.
to begin with physical entanglement and ultimately relies on
the use of secondary, non-covalent bonds, similar to other
first generation mucoadhesive polymers. However, common
chemical modifications (e.g., DOPA, etc.) are also found in
natural mucoadhesive polymers and offer important insight
in to mucoadhesion (Lee et al., 2002; Bré et al., 2013). These
characteristics provide a foundation that allows for tunable drug
release and permeability based on secondary structural elements,
a distinct advantage over many synthetic alternatives.
Chitosan
Chitosan is perhaps the most studied natural mucoadhesive
polymer and has been extensively considered for drug
delivery due to its mucoadhesive and stimuli responsive
nature. Interestingly, without modification, chitosan, a
derivative of shellfish, has an adhesive force that exceeds
both carboxymethylcellulose and polycarbophil, two of the
most common synthetic mucoadhesives used in drug delivery
(Bravo-Osuna et al., 2007; Ngwuluka et al., 2014). This versatile
natural polymer exemplifies the mucoadhesion of the amino
functionality of a cationic polymer to the sialic groups of mucin
through electrostatic interactions at physiological pH (Carvalho
et al., 2010; Kim et al., 2015) and has been used to deliver
many drugs [e.g., metronidazole vaginally (Valenta, 2005), AZT
nasally (Barbi et al., 2015), and pilocarpine ocularly (Li and
Xu, 2002), etc.]. Unfortunately, despite its promise, there are
no FDA approved chitosan drug delivery systems currently
(Kean and Thanou, 2010; Rodrigues et al., 2012; Thakur and
Thakur, 2015). Like PEG, chitosan can be readily functionalized
to improve its mucoadhesion (Andrews et al., 2009). During
the delivery of rhodamine or calcitonin, thiolation of chitosan
has been shown to (1) increase its mucoadhesive strength by
allowing disulfide bridges with mucous glycoprotein cysteine
residues, (2) promote mucous permeation, and (3) prevent
protease activity by sequestering zinc and magnesium, important
cofactors for protease activity (Bernkop-Schnürch et al., 2004a,b;
Grabovac et al., 2005; Bravo-Osuna et al., 2007; Cevher et al.,
2008a). Importantly, thiolation may not be appropriate for
all mucoadhesive drug delivery systems due to formation of
stable, yet short lived, disulfide bonds with mucin, increasing
mucoadhesion up to 130-fold when FITC-dextran was delivered
(Bernkop-Schnürch et al., 2004b; Shaikh et al., 2011; Kim et al.,
2015). Chitosan has also been complexed with catechol, a side
chain of DOPA, to increase in vivo retention and release of
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orally-delivered insulin for up to 10 h, as opposed to less than 3 h
for chitosan alone (Kim et al., 2015). Alternatively, when chitosan
was mixed with a catechol-containing compound, hydrocaffeic
acid, and tested in a rabbit intestine, swelling could be decreased
with a corresponding increase in mucoadhesion and release of
hydrocaffeic acid (Xu et al., 2012). The ability to modify chitosan
and create the specificity of binding, characteristic of a second
generation mucoadhesive, will provide significant advances
in the ability to use chitosan for transmucosal drug delivery,
particularly for membranes with high turn-over.
Viscoelastic spider silk glues
Unlike chitosan, viscoelastic spider silk glues, while long
recognized for their adhesive properties, have yet to find a
niche inmucoadhesive drug delivery. Although previous research
efforts to use spider silk as a drug carrier (Hofmann et al.,
2006; Lammel et al., 2010; Gomes et al., 2012) have focused on
the mechanically robust solid major ampullate and flagelliform
fibers, aggregate silk glue, and even the piriform cement,
are promising mucoadhesive polymer alternatives (Opell and
Hendricks, 2009; Sahni et al., 2010). Recently, the primary
sequences of both piriform (Perry et al., 2010) and aggregate
silk proteins have been determined and the presence of chemical
binders such as DOPA to provide adhesive strength is notably
lacking (Sahni et al., 2011; Jones et al., 2015). Nevertheless,
according to the Dahlquist criteria for adhesives, materials with
robust adhesion should have a Young’s modulus lower than
100 kPa; atomic force microscopy has measured the average
Young’s modulus of aggregate silk glue to be 70± 47 kPa (Torres
et al., 2014). Thus, the fundamental basis of this robust adhesion
may lie in the structural hierarchy, a proteinaceous block
co-polymer composed of two proteins, ASG1 and ASG2, with
a repetitive amino acid motif architecture (Choresh et al., 2009;
Vasanthavada et al., 2012;Wolff et al., 2015). Additionally, similar
to other natural and synthetic mucoadhesive polymers, ASG1 has
a high percentage of charged amino acids, while ASG2 has amotif
structure similar to elastin providing the mobility necessary for
swelling and interaction with mucin (Choresh et al., 2009; Sahni
et al., 2014). This balance of adhesion and elasticity arising from
a composite material is a common theme in natural bioadhesives
(Lee, 2010) and likely leads to effective dissipation of mechanical
forces and mucoadhesion. In fact, the structural hierarchy
and heteromeric composition of these silk glues produces an
anisotropic material that may limit crack propagation, effectively
increasing adhesion strength (Wolff et al., 2015). In addition to
the protein composition and organization, aggregate silk has a
viscous glycoprotein core surrounded by an aqueous solution of
salts (Sahni et al., 2014). Importantly, studies have shown that
the glycoprotein component of aggregate silk glue shares several
characteristics with mammalianmucinmolecules (Choresh et al.,
2009). Currently, aggregate silk has not been specifically assessed
for mucoadhesion; however, its ability to adhere in a high
humidity environment makes it a potentially useful polymer. In
fact, as humidity increases, the adhesive strength of aggregate
silk glue also increases (Opell et al., 2013; Amarpuri et al.,
2015). Although not specifically studied for aggregate silk, a
pH gradient may also solidify aggregate silk providing more
strength and stability similar to major ampullate silk (Breslauer
et al., 2009; Andersson et al., 2013). Further contributing to its
potential as a mucoadhesive polymer, the charge of ASG1 has
a strong similarity to chitin-binding proteins and should react
similarly to changes in pH (Sahni et al., 2014). The composition
and structural organization of aggregate silk in addition to its
environmentally dependent behavior could prove a critical clue
in the use of a silk-based mimetic glue as a mucoadhesive
polymer, specifically for drug delivery.
In addition to a viscous aggregate silk glue, spiders also
produce piriform silk, a cemented attachment disk, as a solid fiber
and fibrous cement composite (Wolff et al., 2015). The cement
component, which has a high content of polar and charged amino
acids similar to other mucoadhesives (Blasingame et al., 2009;
Geurts et al., 2010; Grawe et al., 2014), acts as a viscoelastic
fluid capable of filling surface microarchitecture to provide
a high contact area that heavily relies on hydrogen bonding
for it adhesive strength (Wolff et al., 2015). The anisotropic
organization may again provide a level of robust adhesion not
achieved with other non-silk bioadhesives.
Silkworm-derived adhesives
In contrast to spiders, silkworms can be farmed, providing a level
of accessibility for research and commercialization not currently
possible with spider silk adhesives, which rely on recombinant
development and is still in its infancy. Silkworms produce a
single type fiber with a two chain composite fibroin core and
a sericin coating (Zhang, 2002; Yucel et al., 2010). The core
fibroin is capable of binding to glycoproteins and proteoglycans
(Jiang et al., 2006; Dong et al., 2015). Recently, silkworm fibroin
was solubilized and processed as a pH-sensitive hydrogel via
electrogelation (e-gel) (no drug was released), demonstrating
adhesion likely due to secondary bond interactions (e.g.,
hydrogen bonds and van der Waals interactions). The authors
noted that the promising adhesive strength of these e-gels will
be assessed for their mucoadhesive abilities in future studies
(Yucel et al., 2010). Other efforts to create new “green” silk-based
mucoadhesives have complexed silk fibroin with other synthetic
polymers. Recently, solubilized silkworm fibroin was combined
with a chemically active polyethylene glycol to provide strong
adhesive properties (Serban et al., 2011). At a 20% w/v of silk,
the adhesive strength of the composite was greater than that of
the commercially available CoSeal tissue sealant. Alternatively,
silk fibroin was combined with hydroxy propyl methyl cellulose
(HPMC) and PEG to create a robust mucoadhesive film for
transmucosal drug delivery, although the study did not actually
provide any specific drug release kinetics (Kundu et al., 2008a).
The sericin fraction of silkworm silk, which constitutes 25–
30% of the silk protein and is routinely discarded during
silkworm cocoon processing, can also be blended with a variety of
different polymers including sodium alginate (De, 2003; Khandai
et al., 2010), polyvinylalchol, polyacrylic acid, and acrylamide to
delay and control the release of a pharmaceutical (Ahn et al.,
2001; Zhang, 2002; Khandai et al., 2010). Importantly, sericin
separated from the fibroin core is inherently adhesive as well
(Teramoto and Miyazawa, 2005; Khandai et al., 2010); however,
conjugation of sericin with other polymers is reported to stabilize
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the structure and mitigate residual immunogenicity (Kundu
et al., 2008b).
Caddisfly silk
Analogous to the aggregate silk secreted by orb-weaving
spiders, caddisflies also secrete an adhesive silk-like protein
with impressive strength (Stewart and Wang, 2010; Lane et al.,
2015). However, unlike aggregate silk, sericin, chitosan, and
the DOPA residue similar to that found in the underwater
adhesive of muscles, evidence suggests that the adhesive force of
caddisfly silk results from the post translational phosphorylation
of serine, L-O-phospho-serine (Ser(PO3H2)) (Ashton et al.,
2013). It has been suggested that the caddisfly uses Ser(PO3H2)
providing for very strong adhesion likely due to a combination
of covalent-crosslinking and electrostatic interactions (Stewart
et al., 2011; Ohkawa et al., 2013); however, the precise mechanism
is not clear (Wang et al., 2009). The viscous silk-like substance
and adhesive acts as an underwater cement to adhere small
stones and pebbles to one another to create a protective case;
however, the requirements for adhesion between two hard
surfaces may prove to be very different from that required
for mucoadhesion. Nevertheless, the underwater performance
of the material may prove a compelling reason to consider its
mucoadhesive properties.
MUCOADHESION IN DRUG DELIVERY
Since its inception in the 1980s, mucoadhesion has become an
increasingly popular alternative drug delivery platform due to its
multiple advantages and the advent of multifunctional polymers.
The mechanism of release from the different mucoadhesive
polymers is often dependent on the site, the pH, and the polymer’s
swelling characteristics, but overall release is dominated by
diffusion and swelling with the primary advantage of the system
derived from increased residence time (Yadav et al., 2010; Fini
et al., 2011; Mythri et al., 2011).
Advantages
Residence Time
Arguably, the primary advantage ofmucoadhesivemediated drug
delivery is the increased local residence time at the desired site
of action due to improved contact (Woodley, 2001; Carvalho
et al., 2010; Mythri et al., 2011; Yu et al., 2014). One of the
clearest demonstrations of the effect is in ocular (Dong et al.,
2015) applications where silk fibroin has been used to coat
liposomes for ocular ibuprofen drug delivery to increase the
residence time in the precorneal area of the eye. Similar results
can also be obtained by replacing silk fibroin with chitosan
(Kim et al., 2015), hyaluronan, or cellulose derivatives (Dong
et al., 2015). This feature has recently been demonstrated in
preclinical studies of ophthalmic drug inserts to treat external
ophthalmic diseases in a canine model, which reduced dosing
applications to a single treatment (Baeyens et al., 2002). Examples
of enhanced drug delivery via mucoadhesion, although not
necessarily with silk, can also be found in oral (e.g., FDA-
approved Striant testosterone bucal system), nasal (e.g., insulin),
gastrointestinal (e.g., many antibiotics; Batchelor, 2005), and
vaginal applications (e.g., progesterone; Donnelly and Woolfson,
2015). Additionally, mucoadhesive gels and gel-like particles
with their associated rheological properties decrease the mucous
clearance and increase the contact time, effectively reducing
dosing frequency and increasing patient compliance (Tangri,
2011; Yu et al., 2014).
Enhanced Safety and Efficacy
Mucoadhesive drug delivery often provides enhanced safety and
efficacy rooted in the (1) ability to target the mucosa (Woodley,
2001), (2) improved bioavailability of the drug (Woodley, 2001;
Mythri et al., 2011; Shaikh et al., 2011; Tangri, 2011), (3) abundant
blood flow associated with mucosal surfaces, which will quicken
the onset of action (Tangri, 2011), (4) protection of peptide drugs
from protease degradation (Bernkop-Schnürch et al., 2004b), and
(5) circumvention of first-pass hepatic metabolism (Andrews
et al., 2009). Thiolation has also been reported to enhance
penetration of the drug (Bernkop-Schnürch et al., 2004b). The
nasal administration of insulin as a bioadhesive powder provides
an excellent example of the power of mucoadhesive drug delivery
(Nagai et al., 1984).
Barriers
Unfortunately, several barriers hamper the rapid clinical
translation of mucoadhesive drug delivery. Barriers to the
implementation of successful mucoadhesive drug delivery
systems can be divided into either technical limitations of
characterization or more inherent biological obstacles.
Mechanical Assessment
Evaluation of new mucoadhesive polymers requires both in vitro
and in vivo testing to determine adhesive strength, and yet, as
with most in vivo/in vitro correlations, there is a disconnect
in the methodologies (Khutoryanskiy, 2011). Although there
are three main testing methods recognized—tensile tests, shear
strength, and peel strength with rheology often being included
depending on the proposed application, uniform methodologies
have not been established (Andrews et al., 2009; Davidovich-
Pinhas and Bianco-Peled, 2010; Khutoryanskiy, 2011; Shaikh
et al., 2011; Tangri, 2011; Woertz et al., 2013; Yu et al.,
2014). Khutoryanskiy provides a nice review of the various
testing methods with a discussion of their advantages and
disadvantages (Khutoryanskiy, 2011). Lack of uniform testing
tools not only hampers comparison of mucoadhesive polymers
and drug delivery systems but also proves a critical logistical
barrier to regulatory approval. Additionally, the advent of
nanoscale pharmaceutical therapies has left a significant void in
the methodologies to assess nanoscale mucoadhesion as opposed
to macroscale bulk adhesion (Das Neves et al., 2011).
Biological Factors
In addition to poor methodologies for assessment, many in
vitro assessments are inaccurate in vivo due to biological
factors. Several biological factors can affect the feasibility and
effectiveness of mucoadhesive drug delivery. The precise pH
and microenvironment at the polymer/membrane interface can
significantly impact not only the strength of mucoadhesion but
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also the choice of mucoadhesive polymer (Smart, 2005; Yadav
et al., 2010). Various disease states (e.g., common cold, gastric
ulcer, etc.) can also alter the chemical and physical environment
of the mucous membrane (Mythri et al., 2011; Tangri, 2011).
Prolonged contact with the mucous membrane has also been
reported to cause irritation (Tangri, 2011). Ultimately, mucous
membrane turnover will eventually impact all mucoadhesive
drug formulations (Yadav et al., 2010; Tangri, 2011); however,
use of second generation mucoadhesive polymers that target,
contact, and/or penetrate underlying cells may enhance the
longevity of the adhesive and prove more effective platforms for
mucoadhesive drug delivery (Lehr, 2000).
CONCLUSION
Mucoadhesion is a promising strategy for targeted, controlled
drug delivery. Regardless of the specific molecular mechanism, it
may provemore effective than other controlled delivery strategies
based on (1) the intimate contact provided by the adhesive with
an absorpative membrane, (2) the enhanced retention at the
site of action, (3) the potential protection of sensitive biological
molecules, and (4) the improved bioavailability. Considering
the potential of this drug delivery strategy, development of
additional natural mucoadhesive polymers is paramount. Chief
among these are spider aggregate and piriform silk, silkworm
fibroin and sericin, and caddisfly silk. Based on their recognized
biocompatibility (Ngwuluka et al., 2014), utilizing bioinspired
silk polymers (i.e., aggregate silk, piriform silk, silkworm fibroin,
sericin, and caddisfly silk) may mitigate the immune response
while proving effective for controlled drug delivery.
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